Gilead Sciences Derivative Notional Amount decreased by 10.8% to $3.30B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 43.5%, from $2.30B to $3.30B. Over 4 years (FY 2020 to FY 2024), Derivative Notional Amount shows an upward trend with a 4.8% CAGR.
Changes reflect the scale of hedging activity or speculative positioning within the firm's portfolio.
This is the total face value of the underlying assets in derivative contracts. It is used to determine payments and is a...
Standard disclosure for any firm using derivatives for hedging or investment purposes.
derivative_notional_amount| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.80B | $3.00B | $2.90B | $3.20B | $2.90B | $3.00B | $3.00B | $2.90B | $2.40B | $2.30B | $2.50B | $2.00B | $2.50B | $2.30B | $2.90B | $3.40B | $3.70B | $3.30B |
| QoQ Change | — | +7.1% | -3.3% | +10.3% | -9.4% | +3.4% | +0.0% | -3.3% | -17.2% | -4.2% | +8.7% | -20.0% | +25.0% | -8.0% | +26.1% | +17.2% | +8.8% | -10.8% |
| YoY Change | — | — | — | — | +3.6% | +0.0% | +3.4% | -9.4% | -17.2% | -23.3% | -16.7% | -31.0% | +4.2% | +0.0% | +16.0% | +70.0% | +48.0% | +43.5% |
We use cookies for analytics. See our Privacy and Cookie Policy.